Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of PEEP on Indirect Calorimetry in Critically Ill Patients (IC-PEEP)

29. august 2026 oppdatert av: Carl Sjödin, Vastra Gotaland Region

Effect of Positive End-Expiratory Pressure on Indirect Calorimetry Measurements in Mechanically Ventilated Critically Ill Patients: A Prospective Physiological Study

Indirect calorimetry is used in intensive care to measure how much oxygen a patient consumes and how much carbon dioxide is produced. These measurements are used to estimate energy expenditure and help guide nutritional treatment. In mechanically ventilated patients, however, ventilator settings may potentially influence the accuracy of indirect calorimetry.

This study will investigate whether changes in positive end-expiratory pressure (PEEP), a routinely used ventilator setting, affect measurements obtained by indirect calorimetry in critically ill mechanically ventilated adults.

Each participant will undergo indirect calorimetry at three PEEP levels: 8, 12, and 16 cmH2O. Each PEEP level will be maintained for a stabilization period before measurements are obtained. Other ventilator settings will be kept unchanged during the measurement sequence whenever clinically feasible.

The study will compare oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory quotient (RQ), and resting energy expenditure (REE) across the three PEEP levels. The aim is to determine whether clinically relevant changes in PEEP systematically influence indirect calorimetry measurements and their interpretation.

Studieoversikt

Detaljert beskrivelse

Indirect calorimetry (IC) is considered a reference method for assessment of energy expenditure in critically ill patients. It measures oxygen consumption (VO2) and carbon dioxide production (VCO2), from which respiratory quotient (RQ) and resting energy expenditure (REE) are calculated. Reliable measurements are important when IC is used to guide nutritional therapy in mechanically ventilated intensive care patients.

Measurement accuracy may potentially be influenced by ventilator settings and changes in respiratory mechanics. Positive end-expiratory pressure (PEEP) is frequently adjusted during intensive care, but there is limited clinical evidence regarding whether changes in PEEP within commonly used ranges systematically affect contemporary indirect calorimetry measurements. The approved research project therefore includes a physiological substudy specifically examining the influence of PEEP on VO2, VCO2, RQ, and REE.

This is a prospective, single-center, repeated-measures physiological study conducted in mechanically ventilated adult intensive care patients at Sahlgrenska University Hospital. Participants undergo indirect calorimetry during a standardized sequence of three PEEP levels: 8, 12, and 16 cmH2O. Each participant therefore serves as their own control.

At each PEEP level, the patient is allowed to reach a stable condition before indirect calorimetry measurements are obtained. The ethics protocol specifies a stabilization period before measurement and that other ventilator settings should remain unchanged during the PEEP sequence. The final operational study protocol uses PEEP levels of 8, 12, and 16 cmH2O.

Indirect calorimetry measurements will include VO2, VCO2, RQ, and REE. Measurements will be performed under standardized conditions, with attention to measurement stability and ventilator leakage. In the underlying research protocol, acceptable IC measurement periods are defined using steady-state criteria and controlled ventilator conditions.

The primary objective is to determine whether VO2, VCO2, RQ, and REE change systematically across PEEP levels of 8, 12, and 16 cmH2O. Repeated measurements will be analyzed using mixed-effects models accounting for clustering of observations within participants.

PEEP changes are performed within clinically accepted ranges under continuous intensive care monitoring. The measurement sequence will be interrupted if clinically relevant deterioration in hemodynamics, oxygenation, or other physiological parameters occurs. The ethics protocol specifically requires PEEP changes to remain within clinically acceptable levels and to be discontinued if adverse physiological effects are observed.

A relative difference of 10% in indirect calorimetry-derived measurements between PEEP levels was considered clinically meaningful. Assuming a within-participant standard deviation of approximately 12.5%, corresponding to a standardized paired effect size of 0.8, approximately 15 evaluable participants are required to achieve 80% power at a two-sided alpha level of 0.05. To account for incomplete measurement sequences and technically inadequate indirect calorimetry measurements, 20 participants are planned for enrollment.

Studietype

Intervensjonell

Registrering (Antatt)

20

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Age 18 years or older.
  • Admitted to CIVA or NIVA at Sahlgrenska University Hospital.
  • Receiving invasive mechanical ventilation.
  • Expected intensive care stay longer than 72 hours.
  • Arterial catheter in place.
  • Clinical condition considered sufficiently stable by the responsible physician and research nurse to undergo the study-specific PEEP sequence.
  • PEEP levels of 8, 12, and 16 cmH2O considered clinically acceptable for the participant during the study measurement period.

Exclusion Criteria:

  • Ongoing or planned continuous renal replacement therapy or intermittent hemodialysis (CRRT/iHD).
  • Extracorporeal membrane oxygenation (ECMO).
  • Fraction of inspired oxygen (FiO2) >0.70.
  • Severe renal failure or rapidly increasing creatinine where metabolic measurements may be difficult to interpret.
  • Terminal illness or decision for end-of-life care.
  • Previous participation in the study during the same ICU admission.
  • Clinical instability or other condition judged by the responsible physician to make the PEEP measurement sequence unsafe or inappropriate.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: N/A
  • Intervensjonsmodell: Sekvensiell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Sequential PEEP Levels
All participants undergo indirect calorimetry measurements during a standardized sequence of PEEP levels at 8, 12, and 16 cmH2O. Each PEEP level is maintained for a predefined stabilization period before measurement. Other ventilator settings are kept unchanged whenever clinically feasible. Each participant therefore serves as their own control.
Positive end-expiratory pressure (PEEP) is adjusted sequentially to 8, 12, and 16 cmH2O during a single study session. Each level is maintained until the predefined stabilization criteria are met before indirect calorimetry measurements are obtained. The sequence is performed under continuous intensive care monitoring and is discontinued if clinically relevant deterioration occurs.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Resting Energy Expenditure Across PEEP Levels
Tidsramme: During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
Resting energy expenditure (REE), measured by indirect calorimetry and expressed in kcal/day, will be compared within participants across PEEP levels of 8, 12, and 16 cmH2O. The primary objective is to determine whether changes in PEEP produce systematic and clinically meaningful changes in measured REE.
During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Oxygen Consumption Across PEEP Levels
Tidsramme: During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
VO₂ in mL/min compared within participants at PEEP 8, 12, and 16 cmH₂O.
During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
Carbon Dioxide Production Across PEEP Levels
Tidsramme: During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
VCO₂ in mL/min compared within participants at the three PEEP levels.
During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
Respiratory Quotient Across PEEP Levels
Tidsramme: During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)
RQ calculated as VCO₂/VO₂ and compared within participants at the three PEEP levels.
During a single study session: after approximately 20 minutes at each PEEP level (8, 12, and 16 cmH2O)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. juni 2028

Studiet fullført (Antatt)

1. oktober 2028

Datoer for studieregistrering

Først innsendt

25. august 2026

Først innsendt som oppfylte QC-kriteriene

29. august 2026

Først lagt ut (Faktiske)

1. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

29. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

The feasibility and conditions for sharing de-identified individual participant data have not yet been determined. Any future data sharing will be subject to applicable ethical approvals, data protection regulations, institutional policies, and appropriate data-sharing agreements.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere